MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Hair Glucocorticoids and Functional Movement Disorders Insights from a Cross Sectional Study

VI. Lopez-Diaz, CA. Diaz-Garza, D. León Rojas, F. Luna-Rangel, M. González-González, J. Rodriguez-de-Ita, F. Castorena Torres, D. Martínez-Ramírez (Monterrey, Mexico)

Meeting: 2025 International Congress

Keywords: Psychogenic movement disorders(PMD): Clinical features, Psychogenic movement disorders(PMD): Etiology and Pathogenesis, Psychogenic movement disorders(PMD): Pathophysiology

Category: Functional Movement Disorders / Psychogenic Movement Disorders

Objective: To compare hair glucocorticoid levels between patients with Functional Movement Disorders (FMD) and healthy controls.

Background: FMD are complex neurological conditions that lack specific biomarkers, complicating diagnosis and prognosis. Chronic stress and hypothalamic-pituitary-adrenal axis dysregulation may contribute to their development. While one previous study on hair cortisol found no significant relationship, hair glucocorticoids provide a retrospective measure of long-term stress exposure. This study aimed to assess glucocorticoid levels in FMD patients and controls and compere their relationship with clinical and sociodemographic factors.

Method: This cross-sectional study included 8 FMD patients and 9 controls. Hair samples were analyzed for glucocorticoids using high-performance liquid chromatography. Participants completed questionnaires on motor symptom severity (S-FMDRS), perceived stress (PSS), childhood adverse events (ACE-IQ), anxiety (HAM-A), and depression (Beck Depression Inventory 1). Demographic and clinical data were also collected.

Results: Preliminary analysis revealed no significant differences in cortisol, cortisone, and DHEA levels between groups. Cortisol levels were similar between controls (4.3) and FMD patients (4.0), p=0.80. Cortisone in Control 13.7, Cases 15.4, p=0.84 and DHEA Control 9.2, Cases 6.5, p=0.88 also showed no significant differences. The FMD group was younger (p=0.008). The Beck Depression Inventory indicated greater depression in controls (p=0.03), but this result must be interpreted cautiously due to data heterogeneity. No significant correlations were found between cortisol and perceived stress (p=0.3).

Conclusion: No significant differences were found in cortisol, cortisone, and DHEA levels between FMD patients and controls, suggesting these biomarkers may not clearly differentiate the two groups in this small sample. The heterogeneous data distribution and small sample size necessitate caution in interpreting the results. Larger, more homogeneous studies are needed, along with further investigation into other potential biomarkers. These findings highlight the complexity of FMD and the need for more research to improve understanding of its pathophysiology.

Comparison of Variables between Controls and FMD

Comparison of Variables between Controls and FMD

References: Gonzalez D, Jacobsen D, Ibar C, et al. Hair Cortisol Measurement by an Automated Method. Sci Rep. 2019;9(1):8213. Published 2019 Jun 3. doi:10.1038/s41598-019-44693-3
Maurer CW, LaFaver K, Ameli R, Toledo R, Hallett M. A biological measure of stress levels in patients with functional movement disorders. Parkinsonism Relat Disord. 2015;21(9):1072-1075. doi:10.1016/j.parkreldis.2015.06.017

To cite this abstract in AMA style:

VI. Lopez-Diaz, CA. Diaz-Garza, D. León Rojas, F. Luna-Rangel, M. González-González, J. Rodriguez-de-Ita, F. Castorena Torres, D. Martínez-Ramírez. Hair Glucocorticoids and Functional Movement Disorders Insights from a Cross Sectional Study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/hair-glucocorticoids-and-functional-movement-disorders-insights-from-a-cross-sectional-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/hair-glucocorticoids-and-functional-movement-disorders-insights-from-a-cross-sectional-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley